Canada's Research-Based Pharmaceutical Companies

Canada's Research-Based Pharmaceutical Companies

November 27, 2013 17:13 ET

Canada's Research-Based Pharmaceutical Companies Supports the new Global Markets Action Plan

OTTAWA, ONTARIO--(Marketwired - Nov. 27, 2013) - Today, the Minister of International Trade, the Honourable Ed Fast, launched the Government's Global Markets Action Plan: The Blueprint for Creating Jobs and Opportunities for Canadians Through Trade. This forward looking strategy reflects the changing global landscape as it focuses on core Canadian strengths, and aligns Canada's trade, development and foreign policy tools to advance our commercial interests around the world.

"The signing of the CETA Agreement in Principle is a crowning achievement in support of our Government's Global Commerce Strategy, which will now evolve into the new, and exciting, Global Markets Action Plan," said Mr. Russell Williams, President of Canada's Research-Based Pharmaceutical Companies (Rx&D). "You have identified the life sciences sector and now it is up to us to work with you…we are going to seize this opportunity."

Rx&D is encouraged by the government's vision of promoting linkages to international business partners and international research. Rx&D member companies invest more than $1 billion each year in Canadian life science research - supporting 46,000 jobs and generating $3 billion in wealth for the Canadian economy. This new plan aligns well with Rx&D's ambition to grow the amount of R&D funding that global pharmaceutical companies invest in Canada. It represents the path forward that will help ensure the long-term prosperity of all Canadians in a fiercely competitive global economy.

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents the men and women working for more than 50 member companies which invest more than $1 billion in research and development each year to fuel Canada's knowledge-based economy, contributing over $3 billion to the Canadian economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, private payers, healthcare professionals and stakeholders in a highly ethical manner.

Contact Information